Literature DB >> 15809653

Seeing into cells. The promise of in vivo molecular imaging in oncology.

Daniel C Sullivan1, Gary Kelloff.   

Abstract

Mesh：

Year:  2005        PMID： 15809653      PMCID： PMC1299292          DOI： 10.1038/sj.embor.7400382

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  12 in total

1.  In vivo visualization of gene expression using magnetic resonance imaging.

Authors:  A Y Louie; M M Hüber; E T Ahrens; U Rothbächer; R Moats; R E Jacobs; S E Fraser; T J Meade
Journal:  Nat Biotechnol       Date:  2000-03       Impact factor: 54.908

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 3.  Advances in in vivo bioluminescence imaging of gene expression.

Authors:  Christopher H Contag; Michael H Bachmann
Journal:  Annu Rev Biomed Eng       Date:  2002-03-22       Impact factor: 9.590

4.  Tuberculosis case finding; a comparison of the effectiveness of various roentgenographic and photofluorographic methods.

Authors:  C C BIRKELO; W E CHAMBERLAIN
Journal:  J Am Med Assoc       Date:  1947-02-08

5.  Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample.

Authors:  C A Beam; P M Layde; D C Sullivan
Journal:  Arch Intern Med       Date:  1996-01-22

6.  [18F]fluoroestradiol radiation dosimetry in human PET studies.

Authors:  D A Mankoff; L M Peterson; T J Tewson; J M Link; J R Gralow; M M Graham; K A Krohn
Journal:  J Nucl Med       Date:  2001-04       Impact factor: 10.057

7.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Authors:  Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal:  Radiology       Date:  2004-11       Impact factor: 11.105

8.  In vivo cancer targeting and imaging with semiconductor quantum dots.

Authors:  Xiaohu Gao; Yuanyuan Cui; Richard M Levenson; Leland W K Chung; Shuming Nie
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

Review 9.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

10.  18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

Authors:  S Stroobants; J Goeminne; M Seegers; S Dimitrijevic; P Dupont; J Nuyts; M Martens; B van den Borne; P Cole; R Sciot; H Dumez; S Silberman; L Mortelmans; A van Oosterom
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162
View more
  2 in total

1.  The cutting edge. A synergy of modern surgical techniques and science improves patient survival and recovery.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2007-11       Impact factor: 8.807

2.  Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors.

Authors:  Ferdia A Gallagher; Mikko I Kettunen; De-En Hu; Pernille R Jensen; René In 't Zandt; Magnus Karlsson; Anna Gisselsson; Sarah K Nelson; Timothy H Witney; Sarah E Bohndiek; Georg Hansson; Torben Peitersen; Mathilde H Lerche; Kevin M Brindle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-10       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.